Literature DB >> 2848870

Identification of human immunodeficiency virus (HIV) envelope type-specific T helper cells in an HIV-infected individual.

C M Walker1, K S Steimer, K L Rosenthal, J A Levy.   

Abstract

Two T helper cell clones recognizing the gp 120 envelope protein of HIV were generated from the peripheral blood of a healthy seropositive individual. These cells were type specific as they proliferated and produced IL 2 when stimulated by an epitope in the amino-terminal half of gp 120 of HIVSF2, but not by a similar region of HIVZr6, a Zairian HIV-1 isolate. These two viruses differ by 26% in the deduced amino sequence of the gp 120 protein. Moreover, the antigenic site(s) recognized by the cloned T cells are distinct from those recognized by envelope-specific antibodies. These observations have important implications for the development and use of anti-HIV vaccines.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848870      PMCID: PMC442803          DOI: 10.1172/JCI113841

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes.

Authors:  B H Hahn; M A Gonda; G M Shaw; M Popovic; J A Hoxie; R C Gallo; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

2.  Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins.

Authors:  J M Zarling; J W Eichberg; P A Moran; J McClure; P Sridhar; S L Hu
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

Review 3.  T-cell growth factor.

Authors:  K A Smith
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

4.  Abrogation of anti-Pichinde virus cytotoxic T cell memory by cyclophosphamide and restoration by coinfection or interleukin 2.

Authors:  C M Walker; V Paetkau; W E Rawls; K L Rosenthal
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

5.  Human lymphoblastoid cell lines established from peripheral blood lymphocytes secreting immunoglobulins directed against herpes simplex virus.

Authors:  L Evans; C Maragos; J T May
Journal:  Immunol Lett       Date:  1984       Impact factor: 3.685

6.  Influenza virus-specific human cytotoxic T cell clones: heterogeneity in antigenic specificity and restriction by class II MHC products.

Authors:  D R Kaplan; R Griffith; V L Braciale; T J Braciale
Journal:  Cell Immunol       Date:  1984-10-01       Impact factor: 4.868

7.  Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8.

Authors:  G S Kansas; G S Wood; D M Fishwild; E G Engleman
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

8.  Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.

Authors:  M Yasukawa; J M Zarling
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

9.  Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.

Authors:  J A Levy; A D Hoffman; S M Kramer; J A Landis; J M Shimabukuro; L S Oshiro
Journal:  Science       Date:  1984-08-24       Impact factor: 47.728

10.  Activated B cells express receptors for, and proliferate in response to, pure interleukin 2.

Authors:  R H Zubler; J W Lowenthal; F Erard; N Hashimoto; R Devos; H R MacDonald
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

View more
  3 in total

1.  Inhibitory activity of HIV envelope gp120 dominates over its antigenicity for human T cells.

Authors:  F Manca; L Walker; A Newell; F Celada; J A Habeshaw; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

2.  Enhanced activation of human T cell clones specific for virus-like particles expressing the HIV V3 loop in the presence of HIV V3 loop-specific polyclonal antibodies.

Authors:  S Peifang; G L Pira; D Fenoglio; S Harris; M G Costa; V Venturino; V Dessì; G Layton; J Laman; J G Huisman
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

3.  Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunization.

Authors:  Sara Venturini; Donald E Mosier; Dennis R Burton; Pascal Poignard
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.